Cited by 2,337Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancerCancer-related Molecular Pathways

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, Stephan A., Schutte, Mieke, Shamsul Hoque, A. T. M., Moskaluk, Christopher A., da Costa, Luis T., Rozenblum, Ester, Weinstein, Craig L., Fischer, Aryeh, Yeo, Charles J., Hruban, Ralph H., Kern, Scott E.·1996·Science

DOI 10.1126/science.271.5247.350

Open this paper in CoChat — free account

Abstract

About 90 percent of human pancreatic carcinomas show allelic loss at chromosome 18q. To identify candidate tumor suppressor genes on 18q, a panel of pancreatic carcinomas were analyzed for convergent sites of homozygous deletion. Twenty-five of 84 tumors had homozygous deletions at 18q21.1, a site that excludes DCC (a candidate suppressor gene for colorectal cancer) and includes DPC4 , a gene similar in sequence to a Drosophila melanogaster gene ( Mad ) implicated in a transforming growth factor-β (TGF-β)-like signaling pathway. Potentially inactivating mutations in DPC4 were identified in six of 27 pancreatic carcinomas that did not have homozygous deletions at 18q21.1. These results identify DPC4 as a candidate tumor suppressor gene whose inactivation may play a role in pancreatic and possibly other human cancers.

Integrity signals

Registry

Crossref · 10.1126/science.271.5247.350

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Tumor Suppressor Genes
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760
Self-citation
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking
Liu, Y., & Whittier, R. F. (1995) · Genomics · doi:10.1016/0888-7543(95)80010-j · Cited by 1,141
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Self-citation

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 2

HAHN A. S., IN PRESS CANCER RES .
LEACH S. F., COMMUNICATION .

Sorted by citations

Items 901–1,000 of 1,002

Ski Promotes Tumor Growth Through Abrogation of Transforming Growth Factor-β Signaling in Pancreatic Cancer
Heider, T. R., Lyman, S., Schoonhoven, R., & Behrns, K. E. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318070cafa · Cited by 53
Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin
Bilezikjian, L. M., Justice, N. J., Blackler, A. N., Wiater, E., & Vale, W. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.025 · Cited by 53
The Smad family and its role in pancreatic cancer
Singh, P., Jd, W., & Srinivasan, R. (2011) · Indian Journal of Cancer · doi:10.4103/0019-509x.84939 · Cited by 53
miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression
Zheng, L., Jiao, W., Song, H., Qu, H., Li, D., Mei, H., Chen, Y., Yang, F., Li, H., Huang, K., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.293 · Cited by 53
Pancreatic stellate cells in pancreatic cancer: In focus
Allam, A., Thomsen, A. R., Gothwal, M., Saha, D., Maurer, J., & Brunner, T. B. (2017) · Pancreatology · doi:10.1016/j.pan.2017.05.390 · Cited by 53
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Self-citation
A genetic roadmap of pancreatic cancer: still evolving
Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54
Self-citation
Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms
Abe, T., Fukushima, N., Brune, K. A., Boehm, C. D., Sato, N., Matsubayashi, H., Canto, M. I., Petersen, G. M., Hruban, R. H., & Goggins, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0471 · Cited by 53
Self-citation
Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
Xiangming, C., Natsugoe, S., Takao, S., Hokita, S., Ishigami, S., Tanabe, G., Baba, M., Kuroshima, K., & Aikou, T. (2001) · PubMed · Cited by 53
Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami, S., Matsumoto, N., Nakano, M., Aoki, K., Nagasaki, K., Sügimura, T., Terada, M., & Yoshida, T. (1999) · PubMed · Cited by 53
DPC4 gene mutation in colitis associated neoplasia.
Hoque, A. T. M. S., Hahn, S. A., Schutte, M. E. M., & Kern, S. E. (1997) · Gut · doi:10.1136/gut.40.1.120 · Cited by 53
Self-citation
Recent Discoveries in Cancer Genetics of Exocrine Pancreatic Neoplasia
Hahn, S. A., & Schmiegel, W. (1998) · Digestion · doi:10.1159/000007526 · Cited by 53
Self-citation
Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia
Garcia-Marco, J. A., Caldas, C., Price, C., Wiedemann, L., Ashworth, A., & Catovsky, D. (1996) · Blood · doi:10.1182/blood.v88.5.1568.1568 · Cited by 53
KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
Hamidi, H., Lu, M., Chau, K., Anderson, L., Fejzo, M., Ginther, C., Linnartz, R., Zubel, A., Slamon, D., & Finn, R. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.475 · Cited by 50
Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy
Kim, M. P., Truty, M. J., Choi, W., Kang, Y., Chopin‐Laly, X., Gallick, G. E., Wang, H., McConkey, D. J., Hwang, R. F., Logsdon, C. D., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1839-4 · Cited by 52
Gene Dosage by Quantitative Real-Time PCR
Boulay, J., Reuter, J., Ritschard, R., Terracciano, L., Herrmann, R., & Rochlitz, C. F. (1999) · BioTechniques · doi:10.2144/99272bm03 · Cited by 52
Juvenile Polyposis Syndrome
Keck, K. J., & Howe, J. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-28103-2_6 · Cited by 52
Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
Wang, J., Jin, K., Chen, X.-Y., Lv, J., & Ji, K. (2016) · Oncotarget · doi:10.18632/oncotarget.14335 · Cited by 55
Activins and their receptors in female reproduction
Peng, C., & Mukai, S. T. (2000) · Biochemistry and Cell Biology · doi:10.1139/o00-007 · Cited by 52
Pancreatic adenocarcinoma—Genetic portrait from chromosomes to microarrays
Karhu, R., Mahlamäki, E., & Kallioniemi, A. H. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20337 · Cited by 53
Single small-interfering RNA expression vector for silencing multiple transforming growth factor- pathway components
Jazag, A., Kanai, F., Ijichi, H., Tateishi, K., Ikenoue, T., Tanaka, Y., Ohta, M., Imamura, J., Guleng, B., Asaoka, Y., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni130 · Cited by 52
Tumor Suppressing Pathways
White, R. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81124-1 · Cited by 52
Cloning and Characterization of a Novel Member of the Human Mad Gene Family (MADH6)
Watanabe, T., Suzuki, M., Omori, Y., Hishigaki, H., Horie, M., Kanemoto, N., Fujiwara, T., Nakamura, Y., & Takahashi, E.-I. (1997) · Genomics · doi:10.1006/geno.1997.4753 · Cited by 52
Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer
Ervin, E.-H., French, R., Chang, C., & Pauklin, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.11.001 · Cited by 53
Smad4-dependent TGF-β Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells
Zhao, S., Ammanamanchi, S., Brattain, M. G., Cao, L., Thangasamy, A., Wang, J., & Freeman, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800154200 · Cited by 51
The bone morphogenetic protein system and the regulation of ovarian follicle development in mammals
Rossi, R. O. D. S., Costa, J. J. N., Silva, A. W. B., Saraiva, M. V. A., van den Hurk, R., & Silva, J. R. V. (2015) · Zygote · doi:10.1017/s096719941400077x · Cited by 52
RUNX3 expression in primary and metastatic pancreatic cancer
Li, J., Kleeff, J. H., Guweidhi, A., Esposito, I., Berberat, P. O., Giese, T., Büchler, M. W., & Friess, H. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.013011 · Cited by 51
Growth Factors as Active Participants in Carcinogenesis: A Perspective
Halper, J. T. (2009) · Veterinary Pathology · doi:10.1177/0300985809352981 · Cited by 53
The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
Li, Z., Li, C., Wu, Y., Lan, X., Cao, L., Lichuan, H., Hongyun, W., Wu, Y., Fei, W., & Yazhuo, Z. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-71 · Cited by 51
Desmoplasia and chemoresistance in pancreatic cancer
Whatcott, C. J., Posner, R. G., Hoff, D. D. V., & Han, H. (2012) · Europe PMC (PubMed Central) · Cited by 50
Repression of Smad4 by miR-205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines
Zeng, Y., Zhu, J., Shen, D., Qin, H., Lei, Z., Li, W., Huang, J., & Liu, Z. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3547 · Cited by 52
Transgenic Analysis of the Smad Family of TGF-β Signal Transducers in Drosophila melanogaster Suggests New Roles and New Interactions Between Family Members
Marquez, R. M., Singer, M. A., Takaesu, N. T., Waldrip, W. R., Kraytsberg, Y., & Newfeld, S. J. (2001) · Genetics · doi:10.1093/genetics/157.4.1639 · Cited by 51
PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation
Suzuki, E., Imoto, I., Pimkhaokham, A., Nakagawa, T., Kamata, N., Kozaki, K., Amagasa, T., & Inazawa, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210589 · Cited by 51
Patterning and lineage specification in the amphibian embryo
Chan, A. P.-Y., & Etkin, L. D. (2001) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(01)51001-7 · Cited by 51
BRAM1, a BMP receptor‐associated molecule involved in BMP signalling
Kurozumi, K., Nishita, M., Yamaguchi, T., Fujita, T., Ueno, N., & Shibuyà, H. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00186.x · Cited by 51
Amplification of DNA Sequences from Chromosome 19q13.1 in Human Pancreatic Cell Lines
Curtis, L. J., Li, Y., Gerbault‐Seureau, M., Kuick, R. D., Dutrillaux, A., Goubin, G., Fawcett, J. J., Cram, S., Dutrillaux, B., Hanash, S., et al. (1998) · Genomics · doi:10.1006/geno.1998.5405 · Cited by 51
Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.
Manfredi, M. A. (2010) · PubMed Central · Cited by 50
Comparative analysis of function and interaction of transcription factors in nematodes: Extensive conservation of orthology coupled to rapid sequence evolution
Haerty, W., Artieri, C. G., Khezri, N., Singh, R. S., & Gupta, B. P. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-399 · Cited by 52
SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer
Kwei, K. A., Shain, A. H., Bair, R. J., Montgomery, K. D., Karikari, C. A., van de Rijn, M., Hidalgo, M. M., Maitra, A., Bashyam, M. D., & Pollack, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023924 · Cited by 50
Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: a study matched for T- and N- classification
Tanaka, T., Watanabe, T., Kazama, Y., Tanaka, J., Kanazawa, T., Kazama, S., & Nagawa, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603460 · Cited by 50
Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer
Müller-Pillasch, F., Wallrapp, C., Bartels, K., Varga, G., Frieß, H., Büchler, M. W., Adler, G., & Gress, T. M. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00129-2 · Cited by 50
Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c- myc expression in the absence of TGF-β signaling
Lim, S. K., & Hoffmann, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604773103 · Cited by 50
A rat model of pancreatic ductal adenocarcinoma: Targeting chemical carcinogens
Rivera, J. A., Graeme‐Cook, F., Werner, J., Z’graggen, K., Rustgi, A. K., Rattner, D. W., Warshaw, A. L., & Castillo, C. F. F.-D. (1997) · Surgery · doi:10.1016/s0039-6060(97)90268-3 · Cited by 50
Expression of Functional Schistosoma mansoni Smad4
Osman, A., Niles, E. G., & LoVerde, P. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310949200 · Cited by 52
Activin Type II Receptor Restoration in ACVR2 -Deficient Colon Cancer Cells Induces Transforming Growth Factor-β Response Pathway Genes
Deacu, E., Mori, Y., Sato, F., Yin, J., Olaru, A., Sterian, A., Xu, Y. H., Wang, S., Schulmann, K., Berki, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2082 · Cited by 49
Role of TGF-? in immune-evasion of cancer
Beck, C., Schreiber, H. W., & Rowley, D. A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4 · Cited by 105
New targeted therapies in pancreatic cancer
Seicean, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i20.6127 · Cited by 48
Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice
Xu, X., Ehdaie, B., Ohara, N., Yoshino, T., & Deng, C. (2009) · Oncogene · doi:10.1038/onc.2009.375 · Cited by 49
p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis
Löhr, M. J., Müller, P., Móra, J., Brinkmann, B., Ostwald, C., Farré, A., Lluı́s, F., Adam, U., Stubbe, J., Plath, F., et al. (2001) · Gastrointestinal Endoscopy · doi:10.1067/mge.2001.112711 · Cited by 49
Immunohistochemical Study of DPC4 and p53 Proteins in Gallbladder and Bile Duct Cancers
Chuang, S., Lee, K., Tsai, K., Sheen, P., Nagai, E., Mizumoto, K., & Tanaka, M. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7447-8 · Cited by 49
Genetic Analysis of Invasive Carcinoma Arising in Intraductal Oncocytic Papillary Neoplasm of the Pancreas
Patel, S. A., Adams, R. B., Goldstein, M. L., & Moskaluk, C. A. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00014 · Cited by 49
Self-citation
Clonal Chromosomal Defects in the Molecular Pathogenesis of Refractory Hyperparathyroidism of Uremia
Imanishi, Y., Tahara, H., Palanisamy, N., Spitalny, S., Salusky, I. B., Goodman, W. G., Brandi, M. L., Drüeke, T. B., Sarfati, E., Ureña, P., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018148.50109.c0 · Cited by 49
Targets of Transcriptional Regulation by Transforming Growth Factor‐β: Expression Profile Analysis Using Oligonucleotide Arrays
Akiyoshi, S., Ishii, M., Nemoto, N., Kawabata, M., Aburatani, H., & Miyazono, K. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01090.x · Cited by 49
The transforming growth factor-β signaling pathway in tumorigenesis
Wieser, R. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00014 · Cited by 49
Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes
Bleeker, F. E., Lamba, S., Rodolfo, M., Scarpa, A., Leenstra, S., Vandertop, W. P., & Bardelli, A. (2009) · Human Mutation · doi:10.1002/humu.20927 · Cited by 49
Regulation of urokinase plasminogen activator/plasmin- mediated invasion of melanoma cells by the integrin vitronectin receptor αVβ3
Khatib, A., Nip, J., Fallavollita, L., Lehmann, M., Jensen, G. S., & Brodt, P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999 · Cited by 15
Smad4-expression is decreased in breast cancer tissues: a retrospective study
Stuelten, C. H., Buck, M. B., Dippon, J., Roberts, A. B., Fritz, P., & Knabbe, C. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-25 · Cited by 48
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor–β1‐mediated regulatory abnormalities including up‐regulation of C‐Myc and MTA1
Kidd, M. S., Modlin, I. M., Pfragner, R., Eick, G. N., Champaneria, M. C., Chan, A. K. C., Camp, R. L., & Mane, S. (2007) · Cancer · doi:10.1002/cncr.22725 · Cited by 48
Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF- in Pancreatic Cancer Cell Line PANC-1
Takano, S., Kanai, F., Jazag, A., Ijichi, H., Yao, J. Q., Ogawa, H., Enomoto, N., Omata, M., & Nakao, A. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvm039 · Cited by 51
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition
Jiramongkolchai, P., Owens, P., & Hong, C. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160069 · Cited by 47
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
Sikdar, N., Saha, G., Dutta, A., Ghosh, S., Shrikhande, S. V., & Banerjee, S. (2018) · Current Genomics · doi:10.2174/1389202919666180221160753 · Cited by 51
Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia
Hata, T., Suenaga, M., Marchionni, L., Macgregor-Das, A. M., Yu, J., Shindo, K., Tamura, K., Hruban, R. H., & Goggins, M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.012 · Cited by 49
Self-citation
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
Almeida, P. P., Cardoso, C. P., & de Freitas, L. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-6533-0 · Cited by 48
Smad4 controls signaling robustness and morphogenesis by differentially contributing to the Nodal and BMP pathways
Guglielmi, L., Heliot, C., Kumar, S., Alexandrov, Y., Gori, I., Papaleonidopoulou, F., Barrington, C., East, P., Economou, A. D., French, P. M. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26486-3 · Cited by 47
Pro‐metastasis function of TGFβ mediated by the smad pathway
Kang, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20928 · Cited by 49
c‐Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor‐β signaling in diffuse‐type gastric carcinoma
Kiyono, K., Suzuki, H. I., Morishita, Y., Komuro, A., Iwata, C., Yashiro, M., Hirakawa, K., Kano, M. R., & Miyazono, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01248.x · Cited by 48
DCC: Is there a connection between tumorigenesis and cell guidance molecules?
Fearon, E. R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00023-6 · Cited by 48
Tumor-Suppressor genes in pancreatic cancer
Hruban, R. H., Offerhaus, G. J. A., Kern, S. E., Goggins, M., Wilentz, R. E., & Yeo, C. J. (1998) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050062 · Cited by 48
Self-citation
Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT OncogenesPreprint
Parsons, R. E. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036129 · Cited by 48
Identification of novel Smad2 and Smad3 associated proteins in response to TGF‐β1
Brown, K. A., Ham, A. L., Clark, C., Meller, N., Law, B. K., Chytil, A. M., Cheng, N., Pietenpol, J. A., & Moses, H. L. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21860 · Cited by 47
Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine
Chen, C. (2013) · Medical Science Monitor · doi:10.12659/msm.889636 · Cited by 48
The inherited genetics of pancreatic cancer and prospects for secondary screening
Vitone, L. J., Greenhalf, W., McFaul, C., Ghaneh, P., & Neoptolemos, J. P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.007 · Cited by 46
Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer
Guo, J., Xie, K., & Zheng, S. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14995 · Cited by 47
The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-βSignaling in Breast Cancer Malignancy
Wang, S. E. (2011) · Journal of Signal Transduction · doi:10.1155/2011/804236 · Cited by 49
Inactivation of thePTEN/MMAC1/TEP1 gene in human lung cancers
Kohno, T., Takahashi, M., Manda, R., & Yokota, J. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2 · Cited by 142
Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells
Grau, A. M., Datta, P. K., Zi, J., Halder, S. K., & Beauchamp, R. D. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.021 · Cited by 47
Int7G24A Variant of Transforming Growth Factor-β Receptor Type I Is Associated with Invasive Breast Cancer
Chen, T., Jackson, C. R., Link, A. J., Markey, M. P., Colligan, B. M., Douglass, L. E., Pemberton, J. O., Deddens, J. A., Graff, J. R., & Carter, J. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1518 · Cited by 47
Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study
Svrcek, M., Jourdan, F., Sebbagh, N., Couvelard, A., Chatelain, D., Mourra, N., Olschwang, S., Wendum, D., & Fléjou, J. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.12.898 · Cited by 47
Serine/threonine kinase receptors and ligands
Josso, N., & di Clemente, N. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80151-7 · Cited by 47
Tumor-suppressive and promoting function of transforming growth factor beta
Sun, L. (2004) · Frontiers in bioscience · doi:10.2741/1382 · Cited by 46
Angiogenesis factors in gliomas: a new key to tumour therapy?
Mentlein, R., & Held‐Feindt, J. (2003) · Die Naturwissenschaften · doi:10.1007/s00114-003-0449-9 · Cited by 46
Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHβ promoter activity
Lau, M.-T., & Ge, W. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2004.10.019 · Cited by 46
Epithelial Tight Junctional Changes in Colorectal Cancer Tissues
Wang, X., Tully, O., Ngo, B., Zitin, M., & Mullin, J. M. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.86 · Cited by 46
Targeted Drug Delivery Systems for Pancreatic Cancer
Khare, V. R., Alam, N., Saneja, A., Dubey, R. D., & Gupta, P. N. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.2036 · Cited by 46
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
Dai, C., Rennhack, J. P., Arnoff, T. E., Thaker, M., Younger, S. T., Doench, J. G., Huang, A. Y., Yang, A., Aguirre, A. J., Wang, B. L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109443 · Cited by 45
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival
Kloth, J. N., Kenter, G. G., Spijker, H. S., Kolkman-Uljee, S. M., Corver, W. E., Jordanova, E. S., Fleuren, G. J., & Gorter, A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.62 · Cited by 46
TGFα transgenic mice
Greten, F. R., Wagner, M., Weber, C. K., Zechner, U., Adler, G., & Schmid, R. M. (2001) · Pancreatology · doi:10.1159/000055835 · Cited by 46
Smad7 is a TGF-β-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis
Zhao, J., Crowe, D. L., Castillo, C., Wuenschell, C. W., Chai, Y., & Warburton, D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00281-1 · Cited by 46
Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers
Yanagisawa, K., Uchida, K., Nagatake, M., Masuda, A., Sugiyama, M., Saito, T., Yamaki, K., Takahashi, T., & Osada, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203591 · Cited by 46
Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis
Shi, X., Friess, H., Kleeff, J. H., Ozawa, F., & Büchler, M. W. (2001) · Pancreatology · doi:10.1159/000055854 · Cited by 46
Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions
Murphy, L. O., Cluck, M. W., Lovas, S., Ötvös, F., Murphy, R. F., Schally, A. V., Permert, J., Larsson, J., Knezetic, J. A., & Adrian, T. E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1698 · Cited by 46
TUMOR-ASSOCIATED ANTIGENS: FROM DISCOVERY TO IMMUNITY
Lewis, J. D., Reilly, B. D., & Bright, R. K. (2003) · International Reviews of Immunology · doi:10.1080/08830180305221 · Cited by 47
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
Cheng, H., Fertig, E. J., Ozawa, H., Hatakeyama, H., Howard, J. D., Pérez, J., Considine, M., Thakar, M., Ranaweera, R. S., Krigsfeld, G. S., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056418 · Cited by 45
Circulating transforming growth factor-β-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study
Grau, A. M., Wen, W., Ramroopsingh, D. S., Gao, Y., Zi, J., Cai, Q., Shu, X., & Zheng, W. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9845-8 · Cited by 45
Genetic disruption ofUSP9Xsensitizes colorectal cancer cells to 5-fluorouracil
Harris, D. R., Pike, A. M., & Bunz, F. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21792 · Cited by 45
SMAD 4 alteration associates with invasive‐front pathological markers and poor prognosis in colorectal cancer
Oyanagi, H., Shimada, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Abe, K., Nakano, M., Kameyama, H., Takii, Y., Kawasaki, T., et al. (2019) · Histopathology · doi:10.1111/his.13805 · Cited by 45
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
Fei, N., Wen, S., Ramanathan, R., Hogg, M. E., Zureikat, A. H., Lotze, M. T., Bahary, N., Singhi, A. D., Zeh, H. J., & Boone, B. A. (2021) · Clinical and Translational Science · doi:10.1111/cts.13029 · Cited by 31
SMAD4 Y353C promotes the progression of PDAC
Wang, Z., Li, Y., Zhan, S., Zhang, L., Zhang, S., Tang, Q., Li, M., Tan, Z., Liu, S., & Xing, X. (2019) · BMC Cancer · doi:10.1186/s12885-019-6251-7 · Cited by 25
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Untitled work
Berenson (2001) · doi:10.1002/1097-0142(20010401)91:7
Self-citation

Authors: Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., & Kern, S. E.
Affiliations: Johns Hopkins University (US)
S. A. Hahn, M. Schutte, A. T. M. S. Hoque, C. A. Moskaluk, E. Rozenblum, C. L. Weinstein, A. Fischer, R. H. Hruban, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
L. T. da Costa, Graduate Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Corresponding author: Kern, Scott E.
ORCID: Hahn, Stephan A.
Moskaluk, Christopher A.
Fischer, Aryeh
Yeo, Charles J.
Hruban, Ralph H.
Kern, Scott E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1996-01-19
Volume: 271
Issue: 5247
Pages: 350-353
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.271.5247.350
OpenAlex: W2100522747
Cited by: 2,337
References: 25
Citations by year: 2026: 20 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 31 · 2021: 41 · 2020: 33 · 2019: 44 · 2018: 41 · 2017: 46 · 2016: 55 · 2015: 59 · 2014: 71 · 2013: 64 · 2012: 67
FWCI: 70.80
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: SMAD4, tumor suppressor, pancreatic cancer, homozygous deletion, loss of heterozygosity, TGF-beta signaling, loss-of-function mutations, candidate gene identification
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Cell Division, Chromosome Mapping, Chromosomes, Human, Pair 18, DNA-Binding Proteins, Genetic Markers, Humans, Molecular Sequence Data, Mutation, Neoplasm Transplantation, Pancreatic Neoplasms, Proteins, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Gene Expression, Genes, Tumor Suppressor, Transforming Growth Factor beta, Gene Deletion, Mice, Smad4 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks